These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6161839)

  • 1. Differentiation of solubilized dopamine receptors from spirodecanone binding sites in rat striatum.
    Gorissen H; Ilien B; Aerts G; Laduron P
    FEBS Lett; 1980 Nov; 121(1):133-8. PubMed ID: 6161839
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic activity of four analogs of butaclamol.
    Collu R; Bouvier C; Basak A; Dugas H
    Pharmacol Res Commun; 1985 Dec; 17(12):1153-7. PubMed ID: 2419927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilisation of high-affinity dopamine receptors.
    Gorissen H; Laduron P
    Nature; 1979 May; 279(5708):72-4. PubMed ID: 450076
    [No Abstract]   [Full Text] [Related]  

  • 4. Localization of dopamine receptors in rat brain.
    Reisine TD; Nagy JI; Fibiger HC; Yamamura HI
    Brain Res; 1979 Jun; 169(1):209-14. PubMed ID: 455093
    [No Abstract]   [Full Text] [Related]  

  • 5. Solubilization of neuroleptic/dopamine receptors of human brain striatum.
    Davis A; Madras B; Seeman P
    Eur J Pharmacol; 1981 Mar; 70(3):321-9. PubMed ID: 6112153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- and postnatal ontogeny and characterization of dopaminergic D2, serotonergic S2, and spirodecanone binding sites in rat forebrain.
    Bruinink A; Lichtensteiger W; Schlumpf M
    J Neurochem; 1983 May; 40(5):1227-36. PubMed ID: 6834058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of dopamine, serotonin and spirodecanone receptors in rat forebrain--an autoradiographic study.
    Murrin LC; Gibbens DL; Ferrer JR
    Brain Res; 1985 Nov; 355(1):91-109. PubMed ID: 4075109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity dopamine receptors solubilized from dog striatum [proceedings].
    Gorissen H; Laduron P
    Arch Int Physiol Biochim; 1979 May; 87(2):414-5. PubMed ID: 92960
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes of spirodecanone binding in the gerbil hippocampus after cerebral ischaemia.
    Araki T; Murakami F; Kanai Y; Kato H; Kogure K
    Neuroreport; 1993 Oct; 5(1):37-40. PubMed ID: 8280857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic localization of opioid and spirodecanone receptors in the gerbil hippocampus as compared with the rat hippocampus.
    Onodera H; Kogure K
    J Cereb Blood Flow Metab; 1988 Aug; 8(4):568-74. PubMed ID: 2839528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
    Noguchi-kuno SA; Nakata C; Nishitani H
    Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
    Valchár M; Dobrovský K; Krejcí I; Dlabac A
    Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
    [No Abstract]   [Full Text] [Related]  

  • 14. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor binding in vivo: the feasibility of autoradiographic studies.
    Kuhar MJ; Murrin LC; Malouf AT; Klemm N
    Life Sci; 1978 Jan; 22(2):203-10. PubMed ID: 628311
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug potencies on partially purified brain D2 dopamine receptors.
    Madras BK; Seeman P
    J Neurochem; 1985 Mar; 44(3):856-61. PubMed ID: 2579201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]dihydroergocryptine binding to bovine striatal membranes defined by a low d-butaclamol concentration: antagonism by substituted benzamides.
    Lin CW; Maayani S; Wilk S
    Biochem Pharmacol; 1981 Jun; 30(11):1305-14. PubMed ID: 6168265
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.